Wednesday brings much more Cell and Gene Therapy content, but we’ll also dip into the Marketing and Commercial tracks, looking at real-world evidence, value-based care, and omnichannel mark
At Reuters Pharma USA, a who’s who of executives from major pharma companies will gather in Philadelphia to go in-depth on every part of the business, from marketing and market access to re
Day Three arrives and Reuters Pharma 2023 comes to a close – but not before Boehringer Ingelheim talks to us about accelerating time-to-patient and an expert panel discusses empowering a wh
The US Federal Trade Commission (FTC) has expanded its campaign against so-called ‘junk’ patents intended to extend market exclusivity and block generic rivals.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.